Foresite Capital Opportunity Management V as of Dec. 31, 2021
Portfolio Holdings for Foresite Capital Opportunity Management V
Foresite Capital Opportunity Management V holds 9 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pardes Biosciences | 57.4 | $86M | 5.2M | 16.37 | |
| Cue Health (HLTHQ) | 13.7 | $21M | 1.5M | 13.41 | |
| Quantum-Si Incorporated Com Cl A (QSI) | 8.4 | $13M | 1.6M | 7.87 | |
| Gemini Therapeutics | 4.8 | $7.1M | 2.4M | 2.91 | |
| Theseus Pharmaceuticals | 4.0 | $5.9M | 469k | 12.68 | |
| Cullinan Oncology (CGEM) | 3.9 | $5.9M | 381k | 15.43 | |
| Kinnate Biopharma | 3.5 | $5.2M | 292k | 17.72 | |
| Compass Therapeutics (CMPX) | 2.3 | $3.5M | 1.1M | 3.17 | |
| Adicet Bio (ACET) | 2.0 | $3.0M | 170k | 17.49 |
